These discussions focused on gaps in artificial intelligence, community-based advanced therapy, and demands of federal drug price negotiations.
Ella Hohmann
Advertisement
Articles by Ella Hohmann
Pharmacy benefit manager reforms, gene therapy scale-up, artificial trust risks, and more reshape specialty pharmacy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
5